Skip to main content
Clinical Case Reports logoLink to Clinical Case Reports
. 2025 Jan 30;13(2):e70107. doi: 10.1002/ccr3.70107

Unveiling the Enigma: Idiopathic Digital Infarction—A Case Report and Literature Review

Jaber H Jaradat 1, Wadi Walid I 2,3, Aram F Obeidat 1, Raghad Amro 1, Abdulqadir J Nashwan 4,5,
PMCID: PMC11782845  PMID: 39895848

ABSTRACT

Idiopathic digital infarction (IDI), a rare subset of digital infarction, is characterized by ischemic changes in the absence of identifiable underlying etiology. We present the first documented case of IDI in a 47‐year‐old female with insignificant medical history. Clinical evaluation revealed bluish discoloration of the left lateral three fingers. Negative findings on autoimmune serologies, echocardiogram, and coagulation profiles excluded common causes, such as vasculitis, cardiac embolism, and hypercoagulable states. Imaging studies demonstrated ischemic changes in the left cerebellar hemisphere and proximal left subclavian artery, which supported the diagnosis of acute infarction. The patient was managed conservatively and was discharged. This case underscores the diagnostic complexities of IDI and highlights the importance of thorough evaluation and management.

Keywords: digital infarction, digital ischemia, hand, idiopathic


Summary.

  • This case emphasizes the importance of a comprehensive diagnostic approach for assessing patients with digital infarctions.

  • Physicians must exclude all identifiable etiologies before concluding idiopathic digital infarction.

1. Introduction

Diminished blood perfusion poses a significant threat to tissue viability, progressing from ischemia to eventual tissue death, commonly referred to as infarction. The underlying etiology of ischemia or infarction is diverse, ranging from vasoconstriction or blockage of the supplying vessels to manifestation of systemic diseases such as vasculitis. Digital ischemia results from inadequate blood supply to digital tissue, subsequently leading to digital infarction (DI). The presence of digital pain accompanied by pallor or cyanosis of the skin alarm of impending digital infarction [1]. Idiopathic digital infarction (IDI) is a rare manifestation within the spectrum of digital infarction. Raimbeau et al. estimated the prevalence of IDI is 11.7% [2].

The diagnostic approach for digital infarction commences with a thorough patient history, guiding subsequent investigations, including noninvasive imaging modalities such as Doppler ultrasound (US), angiography, and magnetic resonance angiography (MRA) [1, 3]. Additionally, autoimmune antibodies, such as ANA and ANCA, can provide valuable insights to support diagnosis [4]. However, the diagnosis of idiopathic digital infarction is a diagnosis of exclusion, which is established after other diagnoses have been ruled out.

Effective treatment of digital infarction stems from early diagnosis before tissue viability is lost. Treatment approaches for DI vary from lifestyle changes and avoidance of stressors to medical therapy, such as using vasodilators and vasoprotective drugs [1, 3, 4].

Here, we report the first case report of idiopathic digital infarction in a healthy female. We discussed the possible causes of ID. In this case, the diagnosis was unattainable even after a through examinations, and investigations, and therefore, it is worth reporting, to highlight this rare case, and to encourage future research to identify possible clinical scenarios and underlying causes. We also present a review of the literature over the past 5 years on the causes that might result in digital ischemia/infarction.

2. Case History and Examination

A 47‐year‐old female with no remarkable medical history was admitted via the ER complaining of bluish discoloration of her left lateral three fingers that started 3 months prior to admission (Figure 1). Moreover, she confirmed the absence of experiencing Raynaud's phenomenon. On the physical exam, the patient was stable with no remarkable signs of systemic diseases or cardiovascular diseases. Additionally, there was no oral or genital ulcers, and the patient denied the presence of arthralgia, and other full systemic examination from head to toe was not significant. Blood pressure was 125/90, and her other vitals were within normal range.

FIGURE 1.

FIGURE 1

Shows infraction of the lateral three fingers of the left hand. (A) shows the palmar aspect, involving the distal portions of the lateral three fingers, and (B) shows the dorsal aspect the left hand.

3. Differential Diagnosis and Investigations

Vasculitis was at the top of our differential diagnosis; therefore, we ordered ANA and ANCA tests to confirm the diagnosis, which were negative for both. Therefore, vasculitis was excluded, and we started looking for other underlying causes. Additionally, the patient tested negative for HBsAg and anti‐HCV antibodies. Laboratory tests showed elevated inflammatory markers (ESR = 100 mm/hour, normally ≤ 20 mm/hour) and were positive for CRP (2.77 mg/dL, normally ≤ 0.5 mg/dL) (Table 1). Moreover, complete blood count (CBC) results were within the normal range except for mild elevation in the platelet counts, and creatinine levels were also normal. Coagulation test like PT, PTT, and INR where within normal ranges, and serum levels of protein‐C and anti‐thrombin III were also within normal range. However, platelet counts were slightly elevated about 473,000/μL (normal range 150 to 450 thousand/μL). CTA revealed partial filling defects in the proximal part (near the origin) of the left subclavian artery (Figure 2). The patient reported several episodes of fainting. Brain CT showed subtle hypodensities in the left cerebellar hemisphere (Figure 3). There were neither intra‐ nor extracranial hemorrhages with a normal ventricular system. Brain magnetic resonance imaging (MRI) was used to investigate hypodensities observed on CT. Brain MRI showed an area of abnormal signal intensity with diffusion restriction only in the inferior medial portion of the left cerebellar hemisphere, representing acute ischemic infarction in the left posterior inferior cerebellar artery (PICA) territory without hemorrhagic transformation (Figure 4). On post‐contrast images, grossly preserved enhancements of the vertebral, basilar, and proximal left PICA were observed. There was neither a midline shift nor a mass effect, with no vasogenic edema, the ventricular system was within the normal size, and a partial empty sella was evident (Figure 5). A prominent perioptic subarachnoid space (Figure 6) correlated with signs of increased intracranial pressure (ICP). Normal enhancement of the dural sinuses with no stenosis in the dominant right transverse sinus or thrombosis was observed. An echocardiogram was used to detect what gave rise to the partial filling defect in the left subclavian artery, it revealed mild left ventricular hypertrophy, mitral valve regurgitation grade 1, and trace tricuspid valve regurgitation.

TABLE 1.

Laboratory findings.

Value Reference range
ESR 100 ≤ 20 mm/hour
CRP 2.77 0–0.5 mg/dL
AST 13.0 42.0–54.5 (U/L
RBC 3.89 4.2–5.3 × 106/μL
HB 11.6 11.7–16 g/dL
PCV 34.6 35%–47%
Platelet 473,000/μL 150–450,000/μL
Anti‐thrombin III 103.5% 80%–130%
Protein C 127.4% 70%–140%
Glucose 6.17 4.2–6.4 mmol/L
Creatinine 67 44–80 μmol/L
ANA Negative
ANCA Negative
Anti‐HCV Negative
HBsAg Negative

FIGURE 2.

FIGURE 2

Displays two images obtained through CTA. In images A and B, the arrow points to the partial filling defects are observed in the proximal portion of the left subclavian artery.

FIGURE 3.

FIGURE 3

Shows a brain CT scan. The arrow points to subtle hypodensities in the left cerebellar hemisphere. These hypodensities may indicate various underlying conditions such as ischemia, infarction, or other pathological changes.

FIGURE 4.

FIGURE 4

(A) Shows a T1 intensity MRI, and the arrow points hypointensity in the left cerebellar hemisphere, in the inferior medial portion. (B) shows diffusion restriction MRI, and the arrow points to the area of the diffusion restriction. These changes represent acute ischemic infarction in the left posterior inferior cerebellar artery (PICA) territory without hemorrhagic transformation.

FIGURE 5.

FIGURE 5

The arrows in both picture points to partial empty sella, (A) sagittal plane and (B) coronal plane. Partial empty sella may indicate various pathology, like elevated intracerebral pressure.

FIGURE 6.

FIGURE 6

Shows a brain MRI image revealing with the red arrow pointing to the prominent perioptic subarachnoid space. This area contain CSF, and an enlargement may indicate elevated intracerebral pressure.

4. Treatment

Initially, the patient was treated with anticoagulant (Enoxaparin 80 mg/0.8 mL as Sc injection two times per day) and antiplatelet (aspirin 100 mg orally 1 time per day) drugs, and the digital ischemia stabilized (Figure 1). However, amputation was not performed because the digital ischemia was dry and was not complicated by infection.

5. Follow‐Up

At the 1‐month follow‐up, the patient was well and did not complain of any symptoms, and resolution of the digital infarction was evident.

5.1. Literature Review

A literature review was conducted using the PubMed database, limiting the search to the past 5 years. The following search terms were used: ((“digital ischemia”) NOT (“myocardial” OR “stroke” OR “intestinal” OR “mesenteric” OR “rectal” OR “subtraction”)). This yielded 134 studies; after meticulous exclusion of irrelevant studies, 60 studies were identified as relevant. The scope of the included studies encompassed digital ischemia or infarction regardless of whether they were idiopathic (Table 2). Despite this meticulous search strategy, no case reports specifically addressing idiopathic digital ischemia have been published.

TABLE 2.

Characteristics of patients with digital infarction.

Study ID DOP Age (years) Gender Fingers infarcted The disease underlying the infarction Outcome
Attal et al, (2018) [5] 2018 83 Female Left hand Ranibizumab Auto‐amputation of left fifth distal phalange and complete healing of other fingers
Martins‐Rocha et al, (2020) [6] 2018 14 months Female Right third and fourth Post‐infectious Complete resolution
Hari and Skeik, (2020) [7] 2019 52 Male Bilateral second and right fourth Behcet Complete resolution
Kampoli et al, (2019) [8] 2019 78 Male Right second–fifth, left third Clear‐cell renal‐cell carcinoma ass paraneoplastic Symptomatic improvement
Alzayer and Hasan, (2019) [9] 2019 39 Male Left second and third Hypereosinophilic vasculitis Symptomatic improvement
Khaddour et al, (2019) [10] 2019 68 Female Right first–fourth; left first second, third, and fifth Immune checkpoint inhibitors Progressed to dry gangrene
Zenati et al, (2020) [11] 2019 47 Male Right second Ipilimumab Digital ulceration
Peña Arce et al, (2019) [12] 2019 45 Female Bilateral second–fifth HCV vasculitis Dry gangrene in some fingers
Kurup and Simpson, (2019) [13] 2019 43 Male All fingers Sepsis Complete resolution
Mülkoğlu and Genç, (2019) [14] 2019 37 Female Right third–fifth Hypothenar hammer syndrome Complete resolution
Antonescu et al, (2019) [15] 2019 47 Female All fingers Fibromuscular dysplasia Symptomatic improvement
St‐Pierre et al, (2019) [16] 2019 56 Male Right third, fourth, fifth Hypothenar hammer syndrome Complete resolution
Schultz and Wolf, (2020) [17] 2020

Case 1: 70

Case 2: 43

Case 1: Female

Case 2: Male

Case 1: Right 2nd‐4th

Case 2: Right first and second

Case 1: Covid‐19

Case 2: Covid‐19

Case 1: Ischemia remained stable until she died

Case 2: Eschar formation

Serra‐García et al, (2021) [18] 2020 48 Female Right second–fourth; left fifth Covid‐19 Symptomatic improvement
Cheemalavagu et al, (2020) [19] 2020 50 Female Left second–fourth Adalimumab‐induced antiphospholipid syndrome Complete resolution
Aljahany et al, (2020) [20] 2020 26 Female Right second Epinephrine Complete resolution
Kumar et al, (2020) [21] 2020 45 Female Right first; left second Brachial artery cannulation Surgical amputation
Détriché et al, (2020) [22] 2020 31 Female Left second–fifth Arterial injection of crushed zolpidem Surgical amputation of intermediate and distal phalanges
Imran et al, (2021) [23] 2020 30 Male Right second King cobra bite Ray amputation
Ishii et al, (2020) [24] 2020 61 Female Right third; left second Hypereosinophilic syndrome Complete resolution
Earl, (2020) [25] 2020 46 Female Right second and third Post transradial access Surgical amputation
Martín Pedraz et al, (2022) [26] 2021 11 Male Right fifth Catastrophic antiphospholipid syndrome Complete resolution
Shah et al, (2021) [27] 2021 34 Female Right hand Covid‐19 Progressed to dry gangrene, the patient died before the scheduled amputation
Collado et al, (2021) [28] 2021 48 Female Right second and third; left second Antiphospholipid syndrome and breast cancer Necrosis increased until she died
Jesani et al, (2021) [29] 2021 57 Female All fingers Norepinephrine Progressed to gangrene
Acherjee et al, (2021) [30] 2021 67 Male Right first Covid‐19 Symptomatic improvement
Vulasala et al, (2021) [31] 2021 51 Male Right second; left second–fifth Granulomatosis with polyangiitis causing Raynaud Surgical amputation of three fingers
Jadhav et al, (2021) [32] 2021 18 weeks (26 weeks preterm) Male Right second Septicemia Complete resolution
Schjødt et al, (2021) [33] 2021 75 Male All fingers Covid‐19 + systemic sclerosis Symptomatic improvement
Ravi et al, (2021) [34] 2021 45 Female Left second–fifth Undifferentiated connective tissue disease Auto‐amputation of involved fingers
Klanidhi et al, (2021) [35] 2021 79 Female Right second and fourth; left third and fourth Acral vascular syndrome secondary to lymphoma Gangrene
Rajiah et al, (2021) [36] 2021 32 Male Right first Adrenaline Complete resolution
AlRasbi et al, (2021) [37] 2021 65 Male Right second–fourth Paraneoplastic acral vascular syndrome Resolution of all fingers except third became gangrenous
Swarup et al, (2021) [38] 2021 58 Male Right second Necrotizing granulomatous vasculitis Surgical distal amputation
Potluri et al, (2021) [39] 2021 56 Female All fingers Chemotherapy‐induced raynaud Symptomatic improvement
Hong et al, (2021) [40] 2021 57 Female Right fifth Epinephrine containing nerve block Surgical amputation
Chen et al, (2021) [41] 2021 52 Female Left second–fifth Malignancy associated antiphospholipid syndrome Surgical amputation
Kennedy et al, (2022) [42] 2022 47 Female Left fourth and fifth Post transradial access Surgical amputation of distal phalanges
Huang et al, (2022) [43] 2022 Oxaliplatin
McNamara and Greyson, (2022) [44] 2022 72 Female Right fourth Raynaud + lidocaine and epinephrine injection Wound healed with persistent stiffness
Patel et al, (2022) [45] 2022 41 Male Left all fingers Thenar hammer syndrome Symptomatic improvement
Fuchsberger et al, (2022) [46] 2022 53 Female Left first–third Covid‐19
Niitsuma et al, (2022) [47] 2022 70 Male Right fifth Blunt injury (hypothenar hammer syndrome) Complete resolution
Estíbaliz et al, (2022) [48] 2022 63 Male Right fourth Hypothenar hammer syndrome Complete resolution
Honan et al, (2022) [49] 2022 39 Female Right second and third Systemic sclerosis Complete resolution
Akhlaghi Kalahroodi et al, (2022) [50] 2022 45 Male Left second ANCA vasculitis and antiphospholipid Gangrene
Momen Majumder et al, (2022) [51] 2022 32 Male All fingers Non‐hodgkin lymphoma Surgical amputation
Shoji et al, (2022) [52] 2022 66 Female Left third Systemic sclerosis Complete resolution
Hidalgo Calleja et al, (2023) [53] 2023 60 Female Right second–fifth Graft versus host disease Resolution for all fingers except third
Nayaz et al, (2023) [54] 2023 42 Female Right first Epinephrine Complete resolution
Mateen et al, (2023) [55] 2023 52 Male NR Heparin induced thrombocytopenia NR
Lee et al, (2023) [56] 2023 38 Female Right third–fifth Idiopathic radial artery occlusion Symptomatic improvement
De Hous et al, (2023) [57] 2023 46 Female Left fingers Covid‐19 Unknown
Wangtiraumnuay et al, (2023) [58] 2023 19 months Female Left all fingers Antiphospholipid + paraneoplastic + chemotherapy Surgical amputation
Franco et al, (2023) [59] 2023 65 Female All fingers Systemic sclerosis + multiple myeloma Surgical amputation
Dukan et al, (2023) [60] 2023 36 Male Left second Ruptured digital artery aneurysm Complete resolution
Suwanto et al, (2023) [61] 2023 69 Male Left first, third, and fourth Dialysis access steal syndrome Surgical amputation
Türkel et al, (2023) [62] 2023 54 Female Left fifth Gemcitabine Surgical amputation of distal phalanx
Ibodeng et al, (2023) [63] 2023 41 Female Left fourth and fifth Hypothenar hammer syndrome Complete resolution

Abbreviations: DOP, date of publication; NR, not reported.

6. Discussion

Digital infarction/ischemia is a rare condition with an incidence of 2 per 100,000 persons per year [64, 65], including cardiac or arterial embolism, systemic autoimmune connective tissue disorders (e.g., systemic sclerosis), thromboangiitis obliterans, vasculitis, iatrogenic (drug‐induced, especially chemotherapy [66, 67], or due to operations such as cannulation [21]), paraneoplastic acral vascular syndrome [68], local thrombosis, traumatic injury, and hypothenar hammer syndrome [2]. According to the literature review conducted for this study for all case reports of DI in the last 5 years, an emerging cause is COVID‐19 infection, with the cause of the DI being identified as a hypercoagulable state [69].

The definitive diagnosis of DI is primarily based on the clinical presentation of pain associated with permanent blanching or cyanosis of the digits, along with desquamation and ulceration. In our case, the patient exhibited some elements of this clinical picture, complaining of pain and bluish discoloration without desquamation or ulceration. This presentation led to the diagnosis of DI. However, establishing a specific etiology for our patient proved challenging.

Common causes of DI, such as cardioembolic disease and small vessel vasculitis, were ruled out through an echocardiogram that showed no thrombi in the heart and negative serum levels of ANCA, ANA, HBsAg, and anti‐HCV. A hypercoagulable state was excluded based on a normal coagulation profile, and the patient's non‐smoking status and uneventful obstetric history further supported this exclusion. Slightly elevated platelet counts were considered insignificant as platelet counts are elevated in stressful states, and elevated CRP and ESR supported this conclusion. Additionally, there was no clear history of Raynaud's phenomenon and on examination, there was no digital ulceration which mainly occurs due to the vascular involvement in scleroderma which excludes systemic sclerosis or scleroderma [70]. Moreover, there was no trauma to the affected hand or a medical or surgical history that could predispose to the condition.

Furthermore, the patient's free medical history and not remarkable physical examination along normal vitals led us to exclude paraneoplastic acral vascular syndrome. Consequently, the DI was labeled as idiopathic, given the absence of a specific underlying cause in the patient's clinical presentation.

The patient's high ESR titer and positive CRP align with findings in most cases of idiopathic DI, as reported by Raimbeau et al., where the mean CRP value in the idiopathic group was 28.4 ± 36.9, ranking as the second‐highest mean after the iatrogenic group. Despite this, the discovery is nonspecific, and there may be an alternative underlying etiology.

The treatment regimen involving anticoagulant and antiplatelet drugs in our case proved effective, leading to the patient's discharge without the necessity for more aggressive management options, such as Botox [71], or digital sympathectomy. The latter procedure is associated with long‐term benefits for patients experiencing digital ischemia due to autoimmune conditions [72]. With such a presentation and the absence of predisposing conditions or any significant findings, we present an idiopathic case of digital infarction.

However, diagnosing IDI should be established following excluding other possible causes, absence of the diagnosis should not prevent prompt conservative management like anticoagulant and antiplatelet therapy can prevent further tissue damage and improve patient outcomes. Clinicians should consider IDI in the differential diagnosis of patients presenting with digital ischemia, especially when common causes have been excluded.

In conclusion, idiopathic digital infarction poses diagnostic challenges owing to its rarity and lack of identifiable underlying causes. We present the first case report of IDI in a 47‐year‐old female of the three left lateral fingers. Thorough evaluation, including autoimmune serologies, echocardiogram, and coagulation profiles, ruled out most common causes, such as vasculitis, cardiac embolism, and hypercoagulable states. Imaging studies confirmed acute infarction in the left cerebellar hemisphere and proximal left subclavian artery. Despite the absence of a definitive etiology, the patient responded well to conservative management, emphasizing the importance of early diagnosis and comprehensive evaluation in such cases.

Author Contributions

Jaber H. Jaradat: writing – original draft, writing – review and editing. Wadi Walid I: writing – original draft, writing – review and editing. Aram F. Obeidat: writing – original draft, writing – review and editing. Raghad Amro: writing – original draft, writing – review and editing. Abdulqadir J. Nashwan: writing – original draft, writing – review and editing.

Consent

Written informed consent was obtained from the patient to publish this report, in accordance with the journal's patient consent policy.

Conflicts of Interest

The authors declare no conflicts of interest.

Acknowledgments

Open Access funding provided by the Qatar National Library.

Funding: The authors received no specific funding for this work.

Data Availability Statement

The data presented in this study are available within the article.

References

  • 1. McMahan Z. H. and Wigley F. M., “Raynaud's Phenomenon and Digital Ischemia: A Practical Approach to Risk Stratification, Diagnosis and Management,” International Journal of Clinical Rheumatology 5, no. 3 (2010): 355–370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Raimbeau A., Pistorius M. A., Goueffic Y., et al., “Digital Ischaemia Aetiologies and Mid‐Term Follow‐Up: A Cohort Study of 323 Patients,” Medicine (Baltimore) 100, no. 20 (2021): e25659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Herrick A. L., “The Pathogenesis, Diagnosis and Treatment of Raynaud Phenomenon,” Nature Reviews Rheumatology 8, no. 8 (2012): 469–479. [DOI] [PubMed] [Google Scholar]
  • 4. Wigley F. M., “Clinical practice. Raynaud's Phenomenon,” New England Journal of Medicine 347, no. 13 (2002): 1001–1008. [DOI] [PubMed] [Google Scholar]
  • 5. Attal R., Lazareth I., Angelopoulos G., and Priollet P., “Ranibizumab and Digital Ischemia,” Journal de Medecine Vasculaire 43, no. 1 (2018): 65–69. [DOI] [PubMed] [Google Scholar]
  • 6. Martins‐Rocha T., Matias J. P., Vicente Ferreira M., Mota B., and Brito I., “Post‐Infectious Digital Ischemia Successfully Treated With Iloprost in a Child,” Reumatologia Clinica 16, no. 5 Pt 1 (2020): 364–365. [DOI] [PubMed] [Google Scholar]
  • 7. Hari G. and Skeik N., “Digital Ischemia in Behcet's Disease: Case‐Based Review,” Rheumatology International 40, no. 1 (2020): 137–143. [DOI] [PubMed] [Google Scholar]
  • 8. Kampoli K., Gardeli D., Mouktaroudi M., Fanouriakis A., Lazaris A. M., and Koumarianou A., “Paraneoplastic Digital Ischemia in Clear‐Cell Renal‐Cell Carcinoma: Report of a Case and Review of the Literature,” Urologia 86, no. 3 (2019): 156–160. [DOI] [PubMed] [Google Scholar]
  • 9. Alzayer H. and Hasan M. A., “Hypereosinophilic Vasculitis: A Case Report,” Medicine (Baltimore) 98, no. 17 (2019): e15392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Khaddour K., Singh V., and Shayuk M., “Acral Vascular Necrosis Associated With Immune‐Check Point Inhibitors: Case Report With Literature Review,” BMC Cancer 19, no. 1 (2019): 449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Zenati N., Charles J., Templier I., and Blaise S., “Digital Ischaemia With Fingertip Ulcers During Ipilimumab Therapy,” Annales de Dermatologie et de Vénéréologie 147, no. 3 (2020): 212–216. [DOI] [PubMed] [Google Scholar]
  • 12. Pena Arce C., Ortego Centeno N., Sanchez Cano D., and Perez L. C., “Digital Ischaemia and HCV, a Vasculitis of Uncertain Aetiology,” BML Case Reports 12, no. 6 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Kurup V. and Simpson R. S., “Sepsis‐Induced Digital Ischaemia in a Professional Pianist, in the Absence of Vasopressors,” BML Case Reports 12, no. 10 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Mulkoglu C. and Genc H., “Ulnar Artery Thrombosis Presented With Unilateral Raynaud's Phenomenon Findings After Long‐Term Intensive Handicraft Activity: Hypothenar Hammer Syndrome,” Annals of Vascular Surgery 57, no. 275 (2019): e13–e15. [DOI] [PubMed] [Google Scholar]
  • 15. Antonescu I., Knowles M., Wirtz E., and Pascarella L., “An Unusual Case of Bilateral Upper Extremity Ischemia Caused by Forearm Vessel Fibromuscular Dysplasia,” Annals of Vascular Surgery 56, no. 353 (2019): e7–e11. [DOI] [PubMed] [Google Scholar]
  • 16. St‐Pierre F., Shepherd R. F., and Bartlett M. A., “Diagnosis of Hypothenar Hammer Syndrome in a Patient With Acute Ulnar Artery Occlusion,” BMJ Case Reports 12, no. 9 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Schultz K. and Wolf J. M., “Digital Ischemia in COVID‐19 Patients: Case Report,” Journal of Hand Surgery 45, no. 6 (2020): 518–522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Serra‐Garcia L., Bosch‐Amate X., Alamon‐Reig F., et al., “Digital Ischemia Triggered by Coronavirus Disease 2019 in a Patient Under Cemiplimab Treatment,” International Journal of Dermatology 60, no. 1 (2021): e30–e32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Cheemalavagu S., McCoy S. S., and Knight J. S., “Digital Ischaemia Secondary to Adalimumab‐Induced Antiphospholipid Syndrome,” BML Case Reports 13, no. 2 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Aljahany M. S., Aleid D. K., and Aal Ibrahim A. M., “Reversal of Digital Ischemia With Phentolamine After Accidental Epinephrine Injection,” American Journal of Case Reports 21 (2020): e923877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Kumar V., Salaria A. K., Kumar P., Dogra E., Singh G., and Aggarwal S., “Digital Ischemia Following Brachial Artery Cannulation in a Polytrauma Patient: A Case‐Based Discussion of Etiopathogenesis and Management,” Journal of Orthopaedic Case Reports 10, no. 2 (2020): 40–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Detriche G., Goudot G., Khider L., et al., “Acute Digital Ischemia After Arterial Injection of Crushed Zolpidem Tablets: Role of Microcrystalline Cellulose? A Case Report,” Frontiers in Pharmacology 11 (2020): 560382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Imran R., Vanat Q., Hausien O., and Jose R., “King Cobra Bite—Can Early Decompression Prevent Digital Amputation?,” JPRAS Open 27 (2021): 12–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Ishii K., Mizuuchi T., Yamamoto Y., et al., “Development of Eosinophilic Temporal Arteritis and Digital Ischemia in a Patient With Hypereosinophilic Syndrome,” Internal Medicine 59, no. 10 (2020): 1323–1330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Earl T. J., “Acute Hand Ischemia and Digital Amputation After Transradial Coronary Intervention in a Patient With CREST Syndrome,” Texas Heart Institute Journal 47, no. 4 (2020): 319–321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Martin Pedraz L., Galindo Zavala R., Nieto Vega F., Sanchez Bazan I., and Nunez C. E., “Digital Ischemia as the Initial Presentation of Catastrophic Antiphospholipid Syndrome,” Reumatologia Clinica 18, no. 1 (2022): 56–58. [DOI] [PubMed] [Google Scholar]
  • 27. Shah H., Iyer A., Zaghlol R., and Raparla S., “Case Report: Multiple Strokes and Digital Ischemia in a Young COVID‐19 Patient,” American Journal of Tropical Medicine and Hygiene 104, no. 1 (2021): 60–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Collado M. V., Gandur M. N., Aguilar A., et al., “Triple Negative Breast Cancer, Repeated Abortions and Severe Digital Ischemia,” Medicina 81, no. 2 (2021): 289–292. [PubMed] [Google Scholar]
  • 29. Jesani S., Elkattawy S., Noori M. A. M., et al., “Vasopressor‐Induced Digital Ischemia,” Cureus 13, no. 7 (2021): e16595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Acherjee T., Bastien B., Rodriguez‐Guerra M. A., Salman S., and Ali N., “Digital Ischemia as an Initial Presentation in a COVID‐19‐Positive Patient Without any Significant Respiratory Symptoms,” Cureus 13, no. 3 (2021): e14054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Vulasala S. S., Ahmed S., Onteddu N. K., Mannem M., and Mukkera S., “Raynaud's Secondary to Granulomatosis With Polyangiitis,” Cureus 13, no. 8 (2021): e17551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Jadhav D. V., Mendonca D., Kotinatot S., Shankar S., and Mazmi M. A., “Nitroglycerin Patch Use in Digital Ischemia Secondary to Sepsis: A Case Report,” Pan African Medical Journal 38 (2021): 114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Schjodt M. S., Bech R., and Braae O. A., “Acral Necrosis in a COVID‐19‐Infected Man Treated With Botulinum Toxin Type A,” Case Reports in Dermatology 13, no. 3 (2021): 568–573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Ravi P., Thabah M. M., Verghese R. J., Dineshbabu S., and Kadhiravan T., “Diagnosis of Undifferentiated Connective Tissue Disease in a Patient With Digital Gangrene and Positive Antinuclear Antibodies,” Cureus 13, no. 6 (2021): e15883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Klanidhi K. B., Monian S. A., and Chakrawarty A., “Acral Vascular Syndrome Lennert Type T Cell Lymphoma‐a Case Report,” Journal of the Egyptian National Cancer Institute 33, no. 1 (2021): 8. [DOI] [PubMed] [Google Scholar]
  • 36. Rajiah E., McKean A. R., and Bain C., “Accidental Adrenaline Auto‐Injector‐Induced Digital Ischaemia: A Proposed Treatment Algorithm,” BML Case Reports 14, no. 4 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. AlRasbi S., Al‐Badi A. H., and Al Alawi A. M., “Paraneoplastic Acral Vascular Syndrome: Case Presentation and Literature Review,” BML Case Reports 14, no. 1 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Swarup S., Kopel J., Thein K. Z., et al., “Sequential Complications of Hypercalcemia, Necrotizing Granulomatous Vasculitis, and Aplastic Anemia Occurring in One Patient With Angioimmunoblastic T‐Cell Lymphoma,” American Journal of the Medical Sciences 361, no. 3 (2021): 375–382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Potluri T. K., Lee F. G., Song E., Wallace S. J., and Miller N., “Use of Botulinum Toxin A to Treat Chemotherapy‐Induced Raynaud's Phenomenon,” Cureus 13, no. 1 (2021): e12511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Hong I. S., Moontasri N. J., and Ratliff D. F., “Epinephrine‐Containing Digital Nerve Block: A Case of Digital Tip Necrosis Leading to Amputation in a Patient With no Known Vascular, Rheumatologic, or Smoking History,” Journal of Hand Surgery Global Online 3, no. 4 (2021): 215–217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Chen J. L., Yu X., Luo R., and Liu M., “Severe Digital Ischemia Coexists With Thrombocytopenia in Malignancy‐Associated Antiphospholipid Syndrome: A Case Report and Review of Literature,” World Journal of Clinical Cases 9, no. 36 (2021): 11457–11466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Kennedy P., Klass D., and Chung J., “Non‐target Digital Ischemia in an Ulnar Artery Distribution Following Transradial Access: Case Report and Review of Best Practice Techniques,” Journal of Vascular Access 23, no. 4 (2022): 628–631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Huang C., Storey L., and Chaudhary U., “Digital Ischaemia and Necrosis From Oxaliplatin,” BML Case Reports 15, no. 2 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. McNamara C. T. and Greyson M., “Digital Ischemia After Lidocaine With Epinephrine Injection in a Patient With Primary Raynaud's Phenomena,” Case Reports in Plastic Surgery & Hand Surgery 9, no. 1 (2022): 193–196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Patel S. A., Munshi V., Bayrakdar K., and Guyer A., “A Case of Thenar Hammer Syndrome,” Cureus 14, no. 8 (2022): e28047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Fuchsberger S., Bloch‐Infanger C., and Mang G., “Livid Fingers After Respiratory Infection,” Praxis (1994) 111, no. 16 (2022): 947–950. [DOI] [PubMed] [Google Scholar]
  • 47. Niitsuma G., Kawasaki K., and Inagaki K., “Digital Arterial Occlusion at the Metacarpophalangeal Joint With Hypothenar Hammer Syndrome‐Like Symptoms: A Case Report,” Journal of Orthopaedic Case Reports 12, no. 12 (2022): 1–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Estibaliz A. T., Eztizen L. S., Osman‐Alberto S. A., et al., “Bilateral Hypothenar Hammer Syndrome Case Presentation and Literature Review,” Case Reports in Vascular Medicine 2022 (2022): 2078772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Honan K. A., Romero‐Karam L., Mayes M., and Arain S. A., “Total Percutaneous Revascularization of the Hand to Treat Refractory Digital Ischemia in Advanced Systemic Sclerosis,” JACC Case Report 4, no. 3 (2022): 161–166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Akhlaghi Kalahroodi M., Loghman M., Ramezanpoor M., Shahriarirad R., and Rahmanian E., “Antineutrophil Cytoplasmic Antibody‐Associated Vasculitis in Presence of Positive Antiphospholipid Antibody: A Case Report,” Journal of Medical Case Reports 16, no. 1 (2022): 28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Momen Majumder M. S., Ahmed S., Haque T., et al., “Digital Gangrene: An Unusual Manifestation of Non‐Hodgkin Lymphoma,” Case Reports in Vascular Medicine 2022 (2022): 8963753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Shoji K., Zen K., Yanishi K., and Matoba S., “Successful Endovascular Therapy for Total Occlusion of the Distal Radial and Ulnar Artery with Palmar Artery Lesion in a Patient with Critical Hand Ischemia Associated with Systemic Sclerosis,” Vascular and Endovascular Surgery 56, no. 3 (2022): 340–343. [DOI] [PubMed] [Google Scholar]
  • 53. Hidalgo Calleja C., Montilla Morales C. A., Sanchez Gonzalez M. D., et al., “Critical Digital Ischemia and Biliary Cholangitis Related to Graft Versus Host Disease: A Case Report and Systematic Literature Review,” Medicine (Baltimore) 102, no. 2 (2023): e32495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Nayaz M., Mohamed A., and Nawaz A., “Accidental Digital Ischemia by an Epinephrine Autoinjector,” Cureus 15, no. 3 (2023): e36429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Mateen S., Pontious J., Buckmaster M., and Hasenstein T., “Bilateral Digital Ischemia Secondary to Heparin‐Induced Thrombocytopenia With Subsequent Limb Salvage: A Case Study,” Journal of the American Podiatric Medical Association 113, no. 4 (2023). [DOI] [PubMed] [Google Scholar]
  • 56. Lee N., Gehring M. B., and Washington K. M., “Distal Bypass to the Deep Palmar Arch for Treatment of a Unique Presentation of Digital Ischemia,” Plastic and Reconstructive Surgery. Global Open 11, no. 7 (2023): e5121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. De Hous N., Hollering P., Van Looveren R., Tran T., De Roover D., and Vercauteren S., “Symptomatic Arterial Thrombosis Associated With Novel Coronavirus Disease 2019 (COVID‐19): Report of Two Cases,” Acta Chirurgica Belgica 123, no. 1 (2023): 81–84. [DOI] [PubMed] [Google Scholar]
  • 58. Wangtiraumnuay N., Surakrattanaskul S., and Wangkittikul C., “Digital Gangrene and Antiphospholipid Syndrome in a Retinoblastoma Patient With Chromosome 13q Deletion: A Case Report,” Case Reports in Oncology 16, no. 1 (2023): 287–293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Franco A. S., Polho G. B., Luppino Assad A. P., Miossi R., and Sampaio‐Barros P. D., “Critical Digital Ischaemia in Systemic Sclerosis Exacerbated by Multiple Myeloma: A Case Report,” Journal of Scleroderma and Related Disorders 8, no. 3 (2023): NP9–NP13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Dukan R., Lacroix M., Bertin E., Reverdito G., Fitoussi F., and Binder A. C., “Acute Digit Ischemia due to a Ruptured Digital Collateral Artery Aneurysm in a Patient of Hemophilia: A Case Report,” Journal of Orthopaedic Case Reports 13, no. 11 (2023): 70–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Suwanto D., Dewi I. P., Wardhani L. F. K., Noor Y. A., and Nugroho J., “Recognizing Dialysis Access Steal Syndrome With Central Vein Stenosis as Arteriovenous Fistula Complication: A Case Report,” International Journal of Surgery Case Reports 102 (2023): 107824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Turkel A., Ozdemir M., Kurtulus A., and Dogan M., “Gemcitabine‐Associated Digital Necrosis in Metastatic Breast Cancer,” Journal of Oncology Pharmacy Practice 29, no. 7 (2023): 1770–1775. [DOI] [PubMed] [Google Scholar]
  • 63. Ibodeng G. O., Olagunju O., Chukwurah Q., and Broadwell M., “Hypothenar Hammer Syndrome Presenting as Critical Limb Ischemia in a 41‐Year‐Old Caucasian Female; A Case Report,” Journal of Community Hospital Internal Medicine Perspectives 13, no. 5 (2023): 105–106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Carpentier P. H., Guilmot J. L., Hatron P. Y., et al., “Digital Ischemia, Digital Necrosis,” Journal des Maladies Vasculaires 30, no. 4 Pt 3 (2005): 29–37. [PubMed] [Google Scholar]
  • 65. Pentti J., Salenius J. P., Kuukasjarvi P., and Tarkka M., “Outcome of Surgical Treatment in Acute Upper Limb Ischaemia,” Annales Chirurgiae et Gynaecologiae 84, no. 1 (1995): 25–28. [PubMed] [Google Scholar]
  • 66. Cacoub P., De Lacroix I., Tazi Z., Piette J. C., and Godeau P., “Drug‐Induced Iatrogenic Arterial Diseases,” La Revue de Médecine Interne 16, no. 11 (1995): 827–832. [DOI] [PubMed] [Google Scholar]
  • 67. Schapira D., Nahir A. M., and Hadad N., “Interferon‐Induced Raynaud's Syndrome,” Seminars in Arthritis and Rheumatism 32, no. 3 (2002): 157–162. [DOI] [PubMed] [Google Scholar]
  • 68. Le Besnerais M., Miranda S., Cailleux N., et al., “Digital Ischemia Associated With Cancer: Results From a Cohort Study,” Medicine (Baltimore) 93, no. 10 (2014): e47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Putko R. M., Bedrin M. D., Clark D. M., Piscoya A. S., Dunn J. C., and Nesti L. J., “SARS‐CoV‐2 and Limb Ischemia: A Systematic Review,” Journal of Clinical Orthopaedics and Trauma 12, no. 1 (2021): 194–199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. Ferri C., Valentini G., Cozzi F., et al., “Systemic Sclerosis: Demographic, Clinical, and Serologic Features and Survival in 1,012 Italian Patients,” Medicine (Baltimore) 81, no. 2 (2002): 139–153. [DOI] [PubMed] [Google Scholar]
  • 71. Neumeister M. W., Chambers C. B., and Herron M. S., “Botox Therapy for Ischemic Digits,” Journal of Vascular Surgery 51, no. 2 (2010): 522. [DOI] [PubMed] [Google Scholar]
  • 72. Kotsis S. V. and Chung K. C., “A Systematic Review of the Outcomes of Digital Sympathectomy for Treatment of Chronic Digital Ischemia,” Journal of Rheumatology 30, no. 8 (2003): 1788–1792. [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data presented in this study are available within the article.


Articles from Clinical Case Reports are provided here courtesy of Wiley

RESOURCES